Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Last Updated on: 27 February, 2024|Author: Getaka | Social: X Twitter Profile

Fundamental Analysis of Lyka Labs Ltd

About the Company - Lyka Labs Ltd

Lyka Labs Ltd. is a Public Limited Listed company incorporated on 29/12/1976 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24230GJ1976PLC008738 and registration number is 008738. Currently Company is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 164.35 Cr. and Equity Capital is Rs. 28.69 Cr. for the Year ended 31/03/2022.
Pharmaceuticals4801/B & 4802/A, Ankleshwar Gujarat
NamePosition Held
Mr. Babulal JainChairman
Mr. Kunal GandhiManaging Director & CEO
Mr. Yogesh B ShahExecutive Director & CFO
Mr. Sandeep P ParikhIndependent Director
Mrs. Dhara P ShahIndependent Director
Mr. Prashant GodhaNon Executive Director
Mr. Shashil MendosaNon Executive Director

Lyka Labs Ltd. Share Price Update

Share PriceValue
Previous Day₹138.70

Basic Stock Data of Lyka Labs Ltd

Market Cap 411 Cr.
Current Price 124
High / Low144/88.5
Stock P/E
Book Value 20.6
Dividend Yield0.00 %
ROCE4.93 %
ROE28.4 %
Face Value 10.0

Data Source:

Lyka Labs Ltd Quarterly Results

MonthSep 2020Dec 2020Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
Operating Profit3.466.016.2429.9045.6213.0212.606.315.032.213.302.644.17
OPM %19.82%22.42%25.72%60.48%61.74%36.60%35.81%22.95%19.70%12.40%14.84%11.54%14.90%
Other Income-0.120.70-0.500.47-3.200.58-2.270.950.98-5.950.020.38-0.18
Profit before tax-5.37-2.00-2.6521.3133.336.72-2.120.76-0.64-10.29-3.00-1.80-0.79
Tax %-6.70%7.00%159.25%8.59%16.98%6.55%-607.08%6.58%46.88%-2.24%0.00%-7.22%22.78%
Net Profit-5.75-2.271.1419.5528.436.09-15.070.60-0.38-10.42-3.01-1.85-0.49
EPS in Rs-2.00-0.790.406.819.912.12-5.250.21-0.13-3.63-0.98-0.56-0.15

Lyka Labs Ltd Quarterly Chart

Lyka Labs Ltd Profit & Loss

MonthMar 2012Mar 2013Jun 2014Jun 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023TTM
Operating Profit15288282023-4-2-4201011712
OPM %9%22%7%17%16%21%-6%-3%-6%23%52%18%14%
Other Income1632548-241-300-4-4-6
Profit before tax-80-3-34-8-20-15-62-1459-13-16
Tax %0%0%-45%-31%-5%19%5%59%-1%29%35%0%
Net Profit-8-1-5-54-7-19-6-63-1038-13-16
EPS in Rs-3.20-0.33-3.05-2.291.67-2.51-6.14-1.97-21.10-4.0313.59-4.30-5.32
Dividend Payout %0%0%0%0%0%0%0%0%0%0%0%0%

Lyka Labs Ltd Profit & Loss Yearly Chart

Lyka Labs Ltd Growth

Compounded Sales Growth
10 Years:-3%
5 Years:9%
3 Years:15%
Compounded Profit Growth
10 Years:%
5 Years:11%
3 Years:22%
Stock Price CAGR
10 Years:28%
5 Years:42%
3 Years:64%
1 Year:7%
Return on Equity
10 Years:%
5 Years:%
3 Years:%
Last Year:-28%

Lyka Labs Ltd Balance Sheet

MonthMar 2012Mar 2013Jun 2014Jun 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Sep 2023
Equity Capital22222222222228282929293133
Preference Capital111110111111
Other Liabilities7797114102788869787453435030
Total Liabilities283289329279242252229216200190186152152
Fixed Assets1379316212210413311610810598946863
Other Assets1321431451301079485776866746771
Total Assets283289329279242252229216200190186152152

Lyka Labs Ltd Reserves and Borrowings Chart

Lyka Labs Ltd Cash Flow

MonthMar 2012Mar 2013Jun 2014Jun 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
Cash from Operating Activity 11189271231112759799
Cash from Investing Activity 125-573717-13-3-4-0-0-67
Cash from Financing Activity -16-13-26-60-30-19-10-233-12-63-22
Net Cash Flow-3364-1-0-3-19-310-5

Lyka Labs Ltd Financial Efficiency Indicators

MonthMar 2012Mar 2013Jun 2014Jun 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
Debtor Days131211209124121971257548373579
Inventory Days5799917756901396569415668
Days Payable1582363632202182663012161921419691
Cash Conversion Cycle3073-64-18-41-79-37-75-76-63-555
Working Capital Days6396-106-88-75-191-456-181-156-71634
ROCE %5%10%2%10%7%9%-8%-5%-6%10%61%5%

Lyka Labs Ltd Financial Efficiency Indicators Chart

Lyka Labs Ltd Share Holding Pattern

MonthMar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
No. of Shareholders19,35022,12020,67227,72026,22026,96928,43328,51526,82027,20226,65226,422

Lyka Labs Ltd Shareholding Pattern Chart

No. of Lyka Labs Ltd Shareholders

This stock is not held by any mutual fund

Lyka Labs Ltd ROCE Trend

Lyka Labs Ltd EPS Trend

Lyka Labs Ltd Key Financial Ratios

MonthMar 23Mar 22Mar 21Mar 20Mar 19
Basic EPS (Rs.)-4.6313.57-4.07-21.29-1.79
Diluted EPS (Rs.)-4.6313.57-4.07-21.29-1.79
Cash EPS (Rs.)0.3219.45-0.61-19.030.34
Book Value[Excl.RevalReserv]/Share (Rs.)14.884.70-8.75-5.2716.26
Book Value[Incl.RevalReserv]/Share (Rs.)14.884.70-8.75-5.2716.26
Revenue From Operations / Share (Rs.)30.3367.6530.0621.4325.15
PBDIT / Share (Rs.)6.5935.997.41-0.200.06
PBIT / Share (Rs.)1.9929.944.50-2.99-2.53
PBT / Share (Rs.)-4.2920.65-4.93-21.57-5.48
Net Profit / Share (Rs.)-4.2913.40-3.52-21.83-2.26
NP After MI And SOA / Share (Rs.)-4.3013.59-4.03-21.10-1.97
PBDIT Margin (%)21.7453.1924.63-0.940.27
PBIT Margin (%)6.5444.2514.98-13.96-10.06
PBT Margin (%)-14.1530.52-16.39-100.63-21.79
Net Profit Margin (%)-14.1319.80-11.69-101.84-8.97
NP After MI And SOA Margin (%)-14.1920.09-13.39-98.45-7.84
Return on Networth / Equity (%)-29.07292.380.000.00-12.38
Return on Capital Employeed (%)5.1299.579.17-6.41-5.47
Return On Assets (%)-8.7121.01-6.08-30.24-2.55
Long Term Debt / Equity (X)1.384.63-5.84-8.751.77
Total Debt / Equity (X)1.559.66-6.24-9.752.13
Asset Turnover Ratio (%)0.440.820.300.180.17
Current Ratio (X)1.360.520.590.540.39
Quick Ratio (X)1.140.440.500.430.31
Inventory Turnover Ratio (X)3.054.312.232.121.76
Interest Coverage Ratio (X)1.715.130.81-0.020.02
Interest Coverage Ratio (Post Tax) (X)0.513.230.65-0.460.27
Enterprise Value (Cr.)381.55501.74229.87166.02163.86
EV / Net Operating Revenue (X)4.102.592.672.702.31
EV / EBITDA (X)18.854.8610.82-286.39855.68
MarketCap / Net Operating Revenue (X)3.452.000.860.590.97
Price / BV (X)7.0729.17-2.89-2.551.54
Price / Net Operating Revenue (X)3.452.000.860.590.97

Lyka Labs Ltd Profitability Ratios (%)

Lyka Labs Ltd Liquidity Ratios

Lyka Labs Ltd Liquidity Ratios (%)

Lyka Labs Ltd Interest Coverage Ratios (%)

Lyka Labs Ltd Valuation Ratios

Fair Value of Lyka Labs Ltd Stock

Fair Value: ₹89.51

The stock is overvalued by 27.81% compared to the current price ₹124

*Investments are subject to market risks

Strength and Weakness of Lyka Labs Ltd Stock

  1. The stock has a low average Working Capital Days of -93.75, which is a positive sign.
  2. The stock has a low average Cash Conversion Cycle of -25.00, which is a positive sign.
  3. The company has higher reserves (10.62 cr) compared to borrowings (0.85 cr), indicating strong financial stability.
  1. The stock is trading at a high valuation with an average P/B ratio of 6.18 and average Dividend Yield of 8.35%.
  2. The stock has a low average ROCE of 8.33%, which may not be favorable.
  3. The company has not shown consistent growth in sales (113.69) and profit (-7.62).

About the Author

Author Avatar

Getaka, CFA, a financial analyst with 15 years of experience in the industry. Getaka holds an MBA degree and the Chartered Financial Analyst designation, demonstrating his profound understanding of financial analysis and investment management. Throughout his career, he has conducted numerous financial analyses and due diligence processes for companies in the industry, and has a strong track record of identifying key trends and opportunities. He leverages his expertise to deliver a thorough financial analysis of a company, encompassing its financial performance, key ratios, future prospects, and risks. Getaka is committed to providing accurate, reliable, and trustworthy information to help readers make informed decisions about their finances and investments.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Lyka Labs Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE